# Alexa Meara

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexa-meara/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,428 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 23 |
| i10-index | 39 |
| Last Known Institution | The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute |
| OpenAlex ID | https://openalex.org/A5041997831 |
| ORCID iD | 0000-0002-8406-3556 |
| Works | 115 |

## Researcher papers

- [Update on Lupus Nephritis](https://scholariq.org/papers/update-on-lupus-nephritis/)
- [ANCA-Associated Vasculitis: An Update](https://scholariq.org/papers/anca-associated-vasculitis-an-update/)
- [<p>Analysis of Patient Preferences in Lung Cancer – Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects</p>](https://scholariq.org/papers/and-lt-p-and-gt-analysis-of-patient-preferences-in-lung-cancer-estimating/)
- [Despite high objective numeracy, lower numeric confidence relates to worse financial and medical outcomes](https://scholariq.org/papers/despite-high-objective-numeracy-lower-numeric-confidence-relates-to-worse/)
- [The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2](https://scholariq.org/papers/the-evolution-of-instrument-selection-for-inclusion-in-core-outcome-sets-at/)
- [2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic <scp>Moderate‐to‐Severe</scp> Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective](https://scholariq.org/papers/2023-american-college-of-rheumatology-and-american-association-of-hip-and-knee/)
- [Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol](https://scholariq.org/papers/outcome-measures-in-rheumatology-interventions-for-medication-adherence-omeract/)
- [Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018](https://scholariq.org/papers/update-on-outcome-measure-development-in-large-vessel-vasculitis-report-from/)
- [Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial](https://scholariq.org/papers/individualized-decision-aid-for-diverse-women-with-lupus-nephritis-idea-won-a/)
- [Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review](https://scholariq.org/papers/measurement-properties-of-selected-patient-reported-outcome-measures-for-use-in/)
- [Impact of concurrent glomerulonephritis on outcomes of diffuse alveolar haemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis](https://scholariq.org/papers/impact-of-concurrent-glomerulonephritis-on-outcomes-of-diffuse-alveolar/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Patient-Provider Communication in Healthcare](https://scholariq.org/topics/patient-provider-communication-in-healthcare/)

## Researcher university

- [The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute](https://scholariq.org/institutions/the-ohio-state-university-comprehensive-cancer-center-arthur-g-james-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.